Update Oncology & Haematology Vol 12 Issue 8 August 2026

Over the past few decades, treatments for malignancies in children, adolescents, and young adults (CAYA) have...

Anti-CD7 CAR T cell therapy demonstrates rapid and deep MRD-negative remission in a subset of patients...

Nuclear medicine consists of imaging which displays the functional information of various organs and tissues, and...

A time is coming when chemotherapy will no longer be used to treat chronic lymphocytic leukaemia...

The 19th annual European Association for Haemophilia and Allied Disorders (EAHAD) Congress took place in Dublin...

This educational module explores the critical role of imaging in lung cancer screening, with a particular...

Artificial intelligence (AI) is increasingly part of the conversation about the future of breast screening. The...

The pre-planned interim analysis of the Monumental-3 trial suggests the anti-GPRC5D bispecific antibody talquetamab...

Trauma-informed care is a “powerful equity tool” in cervical screening, states Dr Rachael Comer (PhD), Education...

Blinatumomab (BLI), inotuzumab ozogamicin (INO), and CAR T cell therapy have reshaped the treatment of relapsed/refractory...

The current standard treatment for light chain amyloidosis (AL) is chemotherapy. While often effective, it can...